The US has decided to start making smallpox vaccine again, 20 years after the
disease was officially eradicated, for fear of a biological weapon attack. Some
scientists insist that the existing stockpile of 15 million doses would contain
any smallpox-based attack
(New Scientist, 29 July, p 14). Nevertheless,
BioReliance of Rockville, Maryland, will start work this year on an initial
order of 300 000 doses for the US military. And later this month American health
officials will award a contract to produce a further 40 million doses.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
PCOS postpones perimenopause and allows pregnancies at older ages
2
Red-light therapy does have health benefits but not the ones you think
3
Man destined for Alzheimer's may have been saved by accidental therapy
4
A lost ancient script reveals how writing as we know it really began
5
Woman in cancer remission without treatment in highly unusual case
6
The mathematician who doesn’t exist
7
The best new popular science books of May 2026
8
Hantavirus outbreak will not cause a covid-style pandemic, says WHO
9
The greatest David Attenborough documentaries you really need to watch
10
Coffee's mood-boosting effects aren't just down to caffeine